BG106554A - Ген prv-1 и неговото приложение - Google Patents

Ген prv-1 и неговото приложение Download PDF

Info

Publication number
BG106554A
BG106554A BG106554A BG10655402A BG106554A BG 106554 A BG106554 A BG 106554A BG 106554 A BG106554 A BG 106554A BG 10655402 A BG10655402 A BG 10655402A BG 106554 A BG106554 A BG 106554A
Authority
BG
Bulgaria
Prior art keywords
amino acids
sequence
polypeptide
prv
cells
Prior art date
Application number
BG106554A
Other languages
Bulgarian (bg)
English (en)
Inventor
Heike Pahl
Original Assignee
Universitatsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatsklinikum Freiburg filed Critical Universitatsklinikum Freiburg
Publication of BG106554A publication Critical patent/BG106554A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BG106554A 1999-09-30 2002-03-27 Ген prv-1 и неговото приложение BG106554A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (fr) 1999-09-30 2000-09-29 Gene prv-1 et son utilisation

Publications (1)

Publication Number Publication Date
BG106554A true BG106554A (bg) 2003-01-31

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106554A BG106554A (bg) 1999-09-30 2002-03-27 Ген prv-1 и неговото приложение

Country Status (21)

Country Link
EP (1) EP1220920A1 (fr)
JP (1) JP2003510077A (fr)
KR (1) KR20020047191A (fr)
CN (1) CN1377408A (fr)
AU (1) AU1132401A (fr)
BG (1) BG106554A (fr)
BR (1) BR0014444A (fr)
CA (1) CA2387702A1 (fr)
CZ (1) CZ20021094A3 (fr)
DE (1) DE19947010A1 (fr)
EA (1) EA200200286A1 (fr)
EE (1) EE200200168A (fr)
HR (1) HRP20020269A2 (fr)
HU (1) HUP0203080A2 (fr)
IL (1) IL148770A0 (fr)
MX (1) MXPA02002800A (fr)
NO (1) NO20021498L (fr)
PL (1) PL354184A1 (fr)
SK (1) SK4262002A3 (fr)
WO (1) WO2001023554A1 (fr)
ZA (1) ZA200202379B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
KR102115438B1 (ko) 2012-05-21 2020-05-27 제넨테크, 인크. 혈액-뇌 장벽 수송의 안전성을 개선하는 방법
EP3638774B1 (fr) * 2017-06-14 2024-08-07 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Procédés de purification d'endoderme et de cellules d'endoderme pancréatique dérivées de cellules souches embryonnaires humaines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0991757A1 (fr) * 1997-05-06 2000-04-12 ZymoGenetics Nouveaux antigenes tumoraux
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
EP1141285A2 (fr) * 1998-12-16 2001-10-10 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci

Also Published As

Publication number Publication date
IL148770A0 (en) 2002-09-12
AU1132401A (en) 2001-04-30
WO2001023554A1 (fr) 2001-04-05
CZ20021094A3 (cs) 2002-06-12
SK4262002A3 (en) 2002-09-10
NO20021498D0 (no) 2002-03-26
JP2003510077A (ja) 2003-03-18
ZA200202379B (en) 2003-10-29
EP1220920A1 (fr) 2002-07-10
NO20021498L (no) 2002-05-23
EE200200168A (et) 2003-04-15
EA200200286A1 (ru) 2002-12-26
PL354184A1 (en) 2003-12-29
MXPA02002800A (es) 2002-07-22
DE19947010A1 (de) 2001-04-05
CA2387702A1 (fr) 2001-04-05
KR20020047191A (ko) 2002-06-21
HUP0203080A2 (hu) 2002-12-28
BR0014444A (pt) 2002-06-11
HRP20020269A2 (en) 2003-06-30
CN1377408A (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
JP2002516103A (ja) インターロイキン２１およびインターロイキン２２
JP2001524814A (ja) ２８種類のヒト分泌タンパク質
JP2002518010A (ja) ９４個のヒト分泌タンパク質
CA2129423A1 (fr) Recepteur de facteur de croissance hepatique
JP4452839B2 (ja) Ｃｘｃｒ３阻害剤を含有する医薬組成物
US5858701A (en) DNA encoding an insulin receptor substrate
JPH06503947A (ja) Ｉｇｆｂｐ―５をコードする遺伝物質
WO2011091716A1 (fr) Variante du récepteur du facteur de croissance épidermique
TW201200151A (en) Methods and compositions related to reduced MET phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
BG106554A (bg) Ген prv-1 и неговото приложение
US6686153B1 (en) PRV-1 gene and the use thereof
CN110713544B (zh) 融合基因plekha6-ntrk3及其在lch中的应用
KR100865801B1 (ko) 암 치료의 효능을 증진시키는 방법
WO2012048667A1 (fr) Variant du récepteur de facteur de croissance épidermique à exon manquant
이현채 The Role of Adenylyl Cyclase-Associated Protein1 (CAP1) in Transendothelial Migration of Monocytes to Promote Chronic Inflammation
JP2002512039A (ja) イヌエリスロポエチン遺伝子および組換えタンパク質
JP2003219889A (ja) 新規ｍａｐキナーゼ活性抑制因子
JPWO2004074483A1 (ja) Ｔｓｇ遺伝子ノックアウト動物